C166H199N25O15S — CID 158685261
2-[4-(benzenesulfonamido)piperidin-1-yl]-N-(2-phenyl-3-pyridin-3-ylpropyl)acetamide;tert-butyl N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]carbamate;N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]benzamide;N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]-2-phenylacetamide;2-[4-(phenylcarbamoylamino)piperidin-1-yl]-N-(2-phenyl-3-pyridin-3-ylpropyl)acetamide;phenyl N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]carbamate (PubChem CID 158685261) has the molecular formula C166H199N25O15S and a molecular weight of 2816.64 g/mol. Its IUPAC name is 2-[4-(benzenesulfonamido)piperidin-1-yl]-N-(2-phenyl-3-pyridin-3-ylpropyl)acetamide;tert-butyl N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]carbamate;N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]benzamide;N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]-2-phenylacetamide;2-[4-(phenylcarbamoylamino)piperidin-1-yl]-N-(2-phenyl-3-pyridin-3-ylpropyl)acetamide;phenyl N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]carbamate.
| Compound Name | 2-[4-(benzenesulfonamido)piperidin-1-yl]-N-(2-phenyl-3-pyridin-3-ylpropyl)acetamide;tert-butyl N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]carbamate;N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]benzamide;N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]-2-phenylacetamide;2-[4-(phenylcarbamoylamino)piperidin-1-yl]-N-(2-phenyl-3-pyridin-3-ylpropyl)acetamide;phenyl N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]carbamate |
|---|---|
| PubChem CID | 158685261 |
| Molecular Formula | C166H199N25O15S |
| Molecular Weight | 2816.64 g/mol |
| Exact Mass | 2814.53 |
| IUPAC Name | 2-[4-(benzenesulfonamido)piperidin-1-yl]-N-(2-phenyl-3-pyridin-3-ylpropyl)acetamide;tert-butyl N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]carbamate;N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]benzamide;N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]-2-phenylacetamide;2-[4-(phenylcarbamoylamino)piperidin-1-yl]-N-(2-phenyl-3-pyridin-3-ylpropyl)acetamide;phenyl N-[1-[2-oxo-2-[(2-phenyl-3-pyridin-3-ylpropyl)amino]ethyl]piperidin-4-yl]carbamate |
| SMILES | CC(C)(C)OC(=O)NC1CCN(CC(=O)NCC(Cc2cccnc2)c2ccccc2)CC1.O=C(CN1CCC(NC(=O)Cc2ccccc2)CC1)NCC(Cc1cccnc1)c1ccccc1.O=C(CN1CCC(NC(=O)Nc2ccccc2)CC1)NCC(Cc1cccnc1)c1ccccc1.O=C(CN1CCC(NC(=O)Oc2ccccc2)CC1)NCC(Cc1cccnc1)c1ccccc1.O=C(CN1CCC(NC(=O)c2ccccc2)CC1)NCC(Cc1cccnc1)c1ccccc1.O=C(CN1CCC(NS(=O)(=O)c2ccccc2)CC1)NCC(Cc1cccnc1)c1ccccc1 |
| InChI | InChI=1S/C29H34N4O2.C28H33N5O2.C28H32N4O3.C28H32N4O2.C27H32N4O3S.C26H36N4O3/c34-28(19-23-8-3-1-4-9-23)32-27-13-16-33(17-14-27)22-29(35)31-21-26(25-11-5-2-6-12-25)18-24-10-7-15-30-20-24;34-27(30-20-24(23-9-3-1-4-10-23)18-22-8-7-15-29-19-22)21-33-16-13-26(14-17-33)32-28(35)31-25-11-5-2-6-12-25;33-27(30-20-24(23-9-3-1-4-10-23)18-22-8-7-15-29-19-22)21-32-16-13-25(14-17-32)31-28(34)35-26-11-5-2-6-12-26;33-27(21-32-16-13-26(14-17-32)31-28(34)24-11-5-2-6-12-24)30-20-25(23-9-3-1-4-10-23)18-22-8-7-15-29-19-22;32-27(29-20-24(23-9-3-1-4-10-23)18-22-8-7-15-28-19-22)21-31-16-13-25(14-17-31)30-35(33,34)26-11-5-2-6-12-26;1-26(2,3)33-25(32)29-23-11-14-30(15-12-23)19-24(31)28-18-22(21-9-5-4-6-10-21)16-20-8-7-13-27-17-20/h1-12,15,20,26-27H,13-14,16-19,21-22H2,(H,31,35)(H,32,34);1-12,15,19,24,26H,13-14,16-18,20-21H2,(H,30,34)(H2,31,32,35);1-12,15,19,24-25H,13-14,16-18,20-21H2,(H,30,33)(H,31,34);1-12,15,19,25-26H,13-14,16-18,20-21H2,(H,30,33)(H,31,34);1-12,15,19,24-25,30H,13-14,16-18,20-21H2,(H,29,32);4-10,13,17,22-23H,11-12,14-16,18-19H2,1-3H3,(H,28,31)(H,29,32) |
| InChIKey | IFQRWUYVMNOWQH-UHFFFAOYSA-N |
| XLogP | 20.83 |
| TPSA | 493.54 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 55 |
| Heavy Atoms | 207 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2816.64 |
| LogP ≤ 5 | 20.83 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 27 |